SecBot SecBot
SECBOTREPLAY Home › Report › ESPR

ESPR · Multiple executives at Esperion Therapeutics, including the CEO, CFO,…

Esperion Therapeutics, Inc. · CLUSTER filed Mar 16, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 16, 2026 at 20:00 ET

Multiple executives at Esperion Therapeutics, including the CEO, CFO, and Chief Legal Officer, sold shares in the open market totaling approximately $102,352 over the past week. These sales coincided with large non-cash stock award grants to the same insiders, a routine compensation event, suggesting the sales may be part of pre-arranged 10b5-1 plans or personal liquidity management rather than a signal of fundamental concerns.

  • CEO Sheldon Koenig sold $69,547 worth of shares, representing the largest individual sale in the cluster.
  • CFO Benjamin Halladay and Chief Legal Officer Benjamin Looker sold $17,377 and $15,429 worth of shares, respectively.
  • All three executives received substantial non-cash stock awards on March 13, totaling over 1.8 million shares collectively, which is consistent with annual equity compensation practices.
  • Total open-market sales in the cluster amount to $102,352, representing just 0.015% of the company's $696M market cap, well below the 0.1% threshold for materiality.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access